Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo.

Poignard P, Sabbe R, Picchio GR, Wang M, Gulizia RJ, Katinger H, Parren PW, Mosier DE, Burton DR.

Immunity. 1999 Apr;10(4):431-8.

2.

Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants.

Mosier DE, Picchio GR, Gulizia RJ, Sabbe R, Poignard P, Picard L, Offord RE, Thompson DA, Wilken J.

J Virol. 1999 May;73(5):3544-50.

3.

Inhibition of RNA polymerase II transcription in human cells by synthetic DNA-binding ligands.

Dickinson LA, Gulizia RJ, Trauger JW, Baird EE, Mosier DE, Gottesfeld JM, Dervan PB.

Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):12890-5.

4.

The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.

Picchio GR, Gulizia RJ, Wehrly K, Chesebro B, Mosier DE.

J Virol. 1998 Mar;72(3):2002-9. Erratum in: J Virol 1998 Sep;72(9):7707.

5.
7.
9.

Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site.

Parren PW, Ditzel HJ, Gulizia RJ, Binley JM, Barbas CF 3rd, Burton DR, Mosier DE.

AIDS. 1995 Jun;9(6):F1-6.

PMID:
7662189
10.
11.

Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells.

Reinhardt B, Torbett BE, Gulizia RJ, Reinhardt PP, Spector SA, Mosier DE.

AIDS Res Hum Retroviruses. 1994 Feb;10(2):131-41.

PMID:
8198867
12.

Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates.

Mosier DE, Gulizia RJ, MacIsaac PD, Torbett BE, Levy JA.

Science. 1993 Apr 30;260(5108):689-92.

PMID:
8097595
13.
14.

Homozygous scid/scid;beige/beige mice have low levels of spontaneous or neonatal T cell-induced B cell generation.

Mosier DE, Stell KL, Gulizia RJ, Torbett BE, Gilmore GL.

J Exp Med. 1993 Jan 1;177(1):191-4.

15.

Evaluation of gp160 vaccinees in the hu-PBL-SCID mouse model.

Mosier DE, Gulizia RJ, MacIsaac P, Mathieson BJ, Smith G, Hu SL, Corey L, Greenberg P.

AIDS Res Hum Retroviruses. 1992 Aug;8(8):1387. No abstract available.

PMID:
1466962
16.

Break for SCIDs.

Mosier DE, Gulizia RJ, Torbett BE, Baird SM, Wilson DB.

Nature. 1991 Oct 10;353(6344):509. No abstract available.

PMID:
1922359
17.

Human immunodeficiency virus infection of human-PBL-SCID mice.

Mosier DE, Gulizia RJ, Baird SM, Wilson DB, Spector DH, Spector SA.

Science. 1991 Feb 15;251(4995):791-4.

PMID:
1990441
18.

EBV-associated B-cell lymphomas following transfer of human peripheral blood lymphocytes to mice with severe combined immune deficiency.

Mosier DE, Baird SM, Kirven MB, Gulizia RJ, Wilson DB, Kubayashi R, Picchio G, Garnier JL, Sullivan JL, Kipps TJ.

Curr Top Microbiol Immunol. 1990;166:317-23. No abstract available.

PMID:
1963581
19.

On the SCIDs?

Mosier DE, Gulizia RJ, Baird SM, Wilson DB.

Nature. 1989 Mar 16;338(6212):211. No abstract available.

PMID:
2922049
20.

Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency.

Mosier DE, Gulizia RJ, Baird SM, Spector S, Spector D, Kipps TJ, Fox RI, Carson DA, Cooper N, Richman DD, et al.

Curr Top Microbiol Immunol. 1989;152:195-9.

PMID:
2553338
21.

Transfer of a functional human immune system to mice with severe combined immunodeficiency.

Mosier DE, Gulizia RJ, Baird SM, Wilson DB.

Nature. 1988 Sep 15;335(6187):256-9.

PMID:
2970594

Supplemental Content

Loading ...
Support Center